Literature DB >> 19795451

Does the vesicular stomatitis virus really have a selective oncolytic effect in human cancer?

Amber Yasmeen, Li Zhang, Ala-Eddin Al Moustafa.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 19795451     DOI： 10.1002/ijc.24922

Source DB:  PubMed          Journal:  Int J Cancer        ISSN： 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  3 in total

1.  Immune Consequences of in vitro Infection of Human Peripheral Blood Leukocytes with Vesicular Stomatitis Virus.

Authors:  Tomasz Tomczyk; Grażyna Wróbel; Radosław Chaber; Iwona Siemieniec; Egbert Piasecki; Małgorzata Krzystek-Korpacka; Beata U Orzechowska
Journal:  J Innate Immun       Date:  2018-01-06       Impact factor: 7.349

Review 2.  Targeting pediatric cancer stem cells with oncolytic virotherapy.

Authors:  Gregory K Friedman; Kevin A Cassady; Elizabeth A Beierle; James M Markert; G Yancey Gillespie
Journal:  Pediatr Res       Date:  2012-02-15       Impact factor: 3.756

Review 3.  VSV based virotherapy in ovarian cancer: the past, the present and …future?

Authors:  Beata Urszula Orzechowska; Marcin Jędryka; Katarzyna Zwolińska; Rafał Matkowski
Journal:  J Cancer       Date:  2017-07-22       Impact factor: 4.207
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.